New studies on respiratory syncytial virus (RSV) in both adults and young children show that infections are linked to a ...

A key group of government advisers voted to expand the use of vaccines for a common respiratory illness, providing a boost to ...

Major study shows that adults with respiratory syncytial virus-associated acute respiratory infection face a 2.7-fold higher ...

Researchers from GlaxoSmithKline have reported that a single dose of the RSV vaccine, Arexvy (RSVPreF3 OA), provides ...

Knowledge of respiratory syncytial virus (RSV) disease and RSV vaccine eligibility is low among hospitalized older adults, ...

The CDC's Advisory Committee on Immunization Practices (ACIP) voted 14-0, with one abstention, on Wednesday to recommend that ...

On Wednesday, the Advisory Committee on Immunization Practices (ACIP) voted to expand its recommendation for the use of ...

A recent study highlights the alarming increase in death risk associated with respiratory syncytial virus (RSV) among adults.

Adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) have a 2.7-fold increased risk of death within a year compared to the general population.

Roughly 8000 Brits died from respiratory syncytial virus infections last year, with tens of thousands likely clogging up ...

A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee ...